Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?
Di Lernia
Vito
V
Albertini
Giuseppe
G
D016572:Cyclosporine / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000453:epidemiology*; D006801:Humans; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology*; D012307:Risk Factors
D003879:Dermatologic Agents; D016572:Cyclosporine